While markets await a Saudi update, investors are likely asking how the kingdom left itself so vulnerable, and what it means for the future.Energyread more
Of the recessions the U.S. has seen dating back to the early 1980s, none has come without an oil spike of at least 90%.Economyread more
An oil processing facility at Abqaiq and the nearby Khurais oil field was attacked on Saturday.Marketsread more
Energy stocks, one of the worst-performing sector this year, spiked on Monday after an attack on Saudi Arabia's heart of oil production Saturday sent oil prices soaring.Marketsread more
Shares of defense companies rose on Monday after the United States military was put on alert by President Donald Trump.Marketsread more
The Saudi-led military coalition battling Yemen's Houthi movement said on Monday that the attack on Saudi oil plants was carried out by Iranian weapons and did not originate...Oilread more
Stocks fell on Monday amid fears that a surge in oil prices following an attack in Saudi Arabia could slow down global economic growth.Marketsread more
New research by the Digital Citizens Alliance shows how easy it is to buy illegal steroids and other appearance- and performance-enhancing drugs.Cybersecurityread more
GM shares were down nearly 3% Monday as analysts estimated the strike could cost GM tens of millions of dollars per day. The two sides resumed talks at 10 a.m. Monday...Autosread more
Amazon changed the algorithms that power its product-search system to favor the company's own products, The Wall Street Journal reported.Technologyread more
Between 180 and 200 underperforming GameStop stores are set to shutter before the end of the fiscal year, and more could be on the way.Entertainmentread more
"The thing about sell-offs is that the best stocks tend to go down the hardest. But, and this is a big but, they are also the first to come roaring back," the "Mad Money" host said.
To prepare investors, Cramer revealed his list of stocks to buy ahead of the Fed meeting. He chose these plays based on their ability to rebound after a rate hike. He noted that they are likely to bounce back the best because what prompted their success had nothing to do with the Fed. All of the plays are secular growth stories and have defied naysayers.
Cramer selected the winners by looking at a list of the best-performing stocks in the , Nasdaq and IPOs. Then, he removed players that were on the list due to takeovers, pure commodity stocks that rose because they were down so much going into the year and gold stocks that depend on low rates.
That left Cramer with three categories of stocks: Semiconductors connected to the internet of things and Apple, value stocks that did better than investors thought and companies that built a better mousetrap.
The hottest play on Cramer's list was NVIDIA, because it participates in both the internet of things and gaming chips. He also believes it has significant momentum.
"This one has the most momentum of any stock in the Nasdaq and the S&P 500," Cramer said.
If the Fed does take action, Cramer warned investors not to do anything dramatic. He recommended to protect with a little more cash, but not to dump stocks wholesale.
"I want to explain to you why I feel that we are facing a decline of moderate proportions, one worth riding through if you can stomach it, and nothing more than that. Only the super nimble need to take action," Cramer said.
Though Cramer does not want a rate hike, the market may still get one. While some Fed officials agree with Cramer, he fears that others may lean toward a hike because the U.S. is at "emergency low rates without an emergency."
Cramer drilled down his Fed worries to two issues: whether the Fed tightening matters at all to the economy and whether a quarter point rate hike is already baked into the market.
Cramer saw evidence that investors also worry about a rate hike based on the market's rebound on Monday. Investors who think a quarter-point rate hike will not have an effect confuse the real economy with the stock market, Cramer said.
"For stocks it doesn't matter what WILL happen to the real economy, it matters what people THINK will happen to the real economy," Cramer said.
Another stock that Cramer eyed as a possible buy if the Fed takes action is Charles River Laboratories. Charles River is a research organization for pharma and biotech companies looking to discover new drugs and conduct early stage clinical trials.
Cramer often refers to Charles River as the "arms dealer to the drug industry" and expects companies to spend money on research and development, regardless of political concerns on drug pricing.
"Doesn't matter if the Fed tightens or the economy slows, if you are a pharma or biotech firm, you've got no future if you are not investing in R&D, and in many cases, that means giving money to Charles River," Cramer said.
Charles River reported a strong quarter in August, but has fallen 8 percent since Aug. 1 on no real news. Cramer spoke with the company's CEO and Chairman Jim Foster, who shared the company's advances to humanize mice. Meaning, it has created an animal model to be like a human avatar for the purpose of discovering how a drug is likely to work for humans via translational medicine.
"It's relatively early days, but I think these animal models will become increasingly more important and significant for drug discovery … helping the drug companies to determine whether to continue with a drug is better, or can be better with an animal model," Foster said.
Impinj is an IPO that hit the market at the end of July, and also landed on Cramer's Fed-induced sell-off playbook as a possible opportunity.
Impinj is a play on the internet of things, which is all about connectivity for everyday objects such as appliances, thermostats, and even shoes, among other things. Impinj's radio frequency identification technology provides intelligence to its customers, which refers to the unique identify and location of a product.
The stock has been on fire, as it came public at $14 in July and closed at $34 on Monday. And thanks to the strength of the internet of things, Cramer thinks it could have much more opportunity ahead.
"The stock has had a massive run since it came public in July, and that is why I want you to put this speculative name on your shopping list, and wait for Impinj to come down before you do any buying. Don't worry, I bet you will be able to get the chance in the next couple of weeks," Cramer said.
In the Lightning Round, Cramer gave his take on a few caller favorite stocks:
Advanced Micro Devices: "I think this pullback is an opportunity. They had to fix their balance sheet. That's good. I like their business, they're fine. I just think that once they put all that liquidity out there you have to wait a little bit. Don't expect it to bounce right back to $7 or $8 any time quickly."
GW Pharmaceuticals: "We are big fans of it because they have the actual pill of pure marijuana, none of that other stuff. But the problem is now it is up on a takeover spike, and maybe it gets one. Remember, that is a class one felony to do what they are doing in the United States, but they are over there in London. So, I say you know what, sell half. If you're just starting, I don't want you to give back that big gain."